NCT06539845 Creating a New Health Promotion Module to Help the Indigenous People of Selangor Prepare for Disease X and Outbreaks
| NCT ID | NCT06539845 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universiti Teknologi Mara |
| Condition | Attitude to Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2025-06 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2025-06 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this cluster randomized trial is to develop and test a new method for preparing indigenous (locally termed as Orang Asli) households in Selangor, a state in Malaysia, for outbreaks and Disease X, a potential unknown infectious threat. It aims to determine if the new method, a health education package comprised of workshops, simulation exercises, and card game play sessions, can enhance the readiness of these families for such outbreaks. The main questions it is looking to answer are: 1. Will the intervention package increase the level of preparedness for a Disease X and outbreaks among indigenous households in Selangor? 2. Will the intervention improve the awareness and attitudes of the indigenous people in Selangor towards outbreak preparedness? 3. Will it lead to more proactive preparedness actions by these households? To evaluate the effectiveness of the intervention package, researchers will compare outcomes between two groups: the intervention group receiving both the intervention package and educational brochures on communicable disease prevention, and the control group receiving only the brochures. Participants will: 1. Participate in the activities in the newly developed intervention package, which would include workshops, simulation exercises, and card game play sessions. 2. Answer surveys four times: before, immediately after, 1 month after and 2 months after the intervention, to measure any changes in their preparedness levels for an outbreak.
Eligibility Criteria
Inclusion Criteria: * Orang Asli ethnicity * Malaysian citizen * Age between 18 to 99 years old * The head of the household, or the person who contributes to, or influences health-related decisions for the household * Live in a household with at least three members * Able to converse in Malay Exclusion Criteria: * Having physical or cognitive disabilities (e.g., blindness, deafness, schizophrenia and dementia) * Having severe health conditions (e.g., respiratory and cardiovascular disease requiring oxygen support such as severe asthma/chronic obstructive pulmonary disease/heart failure and congenital heart diseases) * Residing temporarily (less than 2 years) * Intending to relocate to a different residence within the next 2 years
Contact & Investigator
Ameerah Su'ad Abdul Shakor
PRINCIPAL INVESTIGATOR
Universiti Teknologi Mara
Frequently Asked Questions
Who can join the NCT06539845 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Attitude to Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06539845 currently recruiting?
Yes, NCT06539845 is actively recruiting participants. Contact the research team at ameerahsu3ad@gmail.com for enrollment information.
Where is the NCT06539845 trial being conducted?
This trial is being conducted at Gombak, Malaysia, Gombak, Malaysia.
Who is sponsoring the NCT06539845 clinical trial?
NCT06539845 is sponsored by Universiti Teknologi Mara. The principal investigator is Ameerah Su'ad Abdul Shakor at Universiti Teknologi Mara. The trial plans to enroll 96 participants.